GlassScriptPhysician profile
David Quyen Le
NPI 1962566307
$1,479.05
in general payments reported to CMS, 2019-2025
15 companies · $30.05 in 2025
The $30.05 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $480 · 2020: $103 · 2021: $385 · 2022: $297 · 2023: $170 · 2024: $15.79 · 2025: $30.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $215.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $374.19 | 2019-2025 | Stravix |
| Organogenesis INC. | $269.54 | 2019-2022 | |
| Trice Medical, INC. | $174.68 | 2022 | |
| Tenex Health INC. | $153.96 | 2021 | |
| Medtronic, INC. | $120.86 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
| Kci USA, INC. | $107.21 | 2019 | |
| Stryker Corporation | $65.79 | 2019-2024 | Easyfuse, Dart-Fire, Ortholoc 3di Crosscheck |
| Zyla Life Sciences, INC. | $61.61 | 2019-2020 | |
| Melinta Therapeutics, LLC | $41.18 | 2019 | |
| Wright Medical Technology, INC. | $21.61 | 2019 | |
| Nevro Corp. | $21.22 | 2022 | |
| Acera Surgical, INC. | $20.28 | 2023 | Restrata Wound Matrix |
| Abbott Laboratories | $18.16 | 2023 | Proclaim |
| Paratek Pharmaceuticals, INC. | $14.41 | 2022 | |
| Osiris Therapeutics INC. | $14.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.